Anna Tretiakova

984 total citations
24 papers, 581 citations indexed

About

Anna Tretiakova is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Anna Tretiakova has authored 24 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Genetics and 5 papers in Oncology. Recurrent topics in Anna Tretiakova's work include Virus-based gene therapy research (8 papers), Retinal Development and Disorders (5 papers) and CRISPR and Genetic Engineering (4 papers). Anna Tretiakova is often cited by papers focused on Virus-based gene therapy research (8 papers), Retinal Development and Disorders (5 papers) and CRISPR and Genetic Engineering (4 papers). Anna Tretiakova collaborates with scholars based in United States, Canada and Austria. Anna Tretiakova's co-authors include Kamel Khalili, Shohreh Amini, Edward M. Johnson, James M. Wilson, Gary L. Gallia, Maria P. Limberis, Virginie Adam, Nune Darbinian, Bradford A. Jameson and Natalia Shcherbik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Anna Tretiakova

22 papers receiving 576 citations

Peers

Anna Tretiakova
Amélie Robert Canada
R. Stephens United States
Volker Patzel Germany
Kathryn S. Campbell United States
Patrick Champion-Arnaud France
Marc S. Krug United States
Aarthi Ashok United States
Gregory E. Tullis United States
Toru Uchiyama Japan
Erika Marsilio United States
Amélie Robert Canada
Anna Tretiakova
Citations per year, relative to Anna Tretiakova Anna Tretiakova (= 1×) peers Amélie Robert

Countries citing papers authored by Anna Tretiakova

Since Specialization
Citations

This map shows the geographic impact of Anna Tretiakova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tretiakova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tretiakova more than expected).

Fields of papers citing papers by Anna Tretiakova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Tretiakova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tretiakova. The network helps show where Anna Tretiakova may publish in the future.

Co-authorship network of co-authors of Anna Tretiakova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Tretiakova. A scholar is included among the top collaborators of Anna Tretiakova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Tretiakova. Anna Tretiakova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henry, Timothy D., Eugene Chung, Lothar Roessig, et al.. (2025). GenePHIT Phase 2 Study Design: A Double Blind, Placebo-controlled Trial To Assess Efficacy, Safety, And Tolerability Of Ab-1002 Gene Therapy In Adults With Heart Failure. Journal of Cardiac Failure. 31(1). 234–234. 2 indexed citations
2.
Henry, Timothy D., Eugene Chung, M.F. Alvisi, et al.. (2024). GenePHIT phase 2 study design: a double blind, placebo-controlled trial to assess efficacy, safety, and tolerability of AB-1002 gene therapy in adults with heart failure. European Heart Journal. 45(Supplement_1). 1 indexed citations
3.
Krause, Charles R., et al.. (2022). Thermostability and in vivo performance of AAV9 in a film matrix. SHILAP Revista de lepidopterología. 2(1). 148–148. 8 indexed citations
4.
Lyubarsky, Arkady, Tomás S. Alemán, Albert M. Maguire, et al.. (2018). Safety of subretinal delivery of RGX-314 (AAV8-anti-VEGF Fab) in the non-human primate as assessed by full-field ERG. Investigative Ophthalmology & Visual Science. 59(9). 4546–4546. 1 indexed citations
5.
Ammar, Michael J., Katherine E. Uyhazi, Arkady Lyubarsky, et al.. (2018). Safety of the Subretinal Delivery of RGX-314 AAV8-anti-VEGF Fab Gene Therapy in NHP: Retinal Structure Over One Year. Investigative Ophthalmology & Visual Science. 59(9). 1422–1422. 2 indexed citations
6.
Bell, Peter, et al.. (2018). Preparation of Nonhuman Primate Eyes for Histological Evaluation After Retinal Gene Transfer. Human Gene Therapy Methods. 29(3). 115–123.
7.
Tretiakova, Anna, Tomás S. Alemán, Arkady Lyubarsky, et al.. (2017). Subretinal delivery of RGX-314 AAV8-anti-VEGF Fab gene therapy in NHP. Investigative Ophthalmology & Visual Science. 58(8). 4509–4509. 1 indexed citations
8.
Liu, Yuanyuan, Seth D. Fortmann, Jikui Shen, et al.. (2017). AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration. Molecular Therapy. 26(2). 542–549. 40 indexed citations
9.
10.
Limberis, Maria P., Anna Tretiakova, Kalyani Nambiar, et al.. (2016). Adeno-Associated Virus Serotype 9-Expressed ZMapp in Mice Confers Protection Against Systemic and Airway-Acquired Ebola Virus Infection. The Journal of Infectious Diseases. 214(12). 1975–1979. 14 indexed citations
11.
Adam, Virginie, Marco Crosariol, Sachin Kumar, et al.. (2014). Adeno-Associated Virus 9-Mediated Airway Expression of Antibody Protects Old and Immunodeficient Mice against Influenza Virus. Clinical and Vaccine Immunology. 21(11). 1528–1533. 29 indexed citations
12.
Loll, Patrick J., Anna Tretiakova, & Erik J. Soderblom. (2003). Compatibility of detergents with the microbatch-under-oil crystallization method. Acta Crystallographica Section D Biological Crystallography. 59(6). 1114–1116. 10 indexed citations
13.
Sieroń, Aleksander L., Anna Tretiakova, Bradford A. Jameson, et al.. (2000). Structure and Function of Procollagen C-Proteinase (mTolloid) Domains Determined by Protease Digestion, Circular Dichroism, Binding to Procollagen Type I, and Computer Modeling. Biochemistry. 39(12). 3231–3239. 44 indexed citations
14.
Tretiakova, Anna, et al.. (1999). Regulation of myelin basic protein gene transcription by Sp1 and Pur?: Evidence for association of Sp1 and Pur? in brain. Journal of Cellular Physiology. 181(1). 160–168. 72 indexed citations
15.
Tretiakova, Anna, Barbara Krynska, Jennifer Gordon, & Kamel Khalili. (1999). Human neurotropic JC virus early protein deregulates glial cell cycle pathway and impairs cell differentiation. Journal of Neuroscience Research. 55(5). 588–599. 23 indexed citations
16.
Darbinian, Nune, Gary L. Gallia, Mondira Kundu, et al.. (1999). Association of Purα and E2F-1 suppresses transcriptional activity of E2F-1. Oncogene. 18(46). 6398–6402. 47 indexed citations
17.
Krynska, Barbara, et al.. (1998). MyEF-3, a Developmentally Controlled Brain-Derived Nuclear Protein Which Specifically Interacts with Myelin Basic Protein Proximal Regulatory Sequences. Biochemical and Biophysical Research Communications. 243(1). 295–301. 31 indexed citations
18.
Baier‐Bitterlich, Gabriele, et al.. (1998). Structure and function of HIV-1 and SIV Tat proteins based on carboxy-terminal truncations, chimeric Tat constructs, and NMR modeling. Biomedicine & Pharmacotherapy. 52(10). 421–430. 5 indexed citations
19.
Tretiakova, Anna, Gary L. Gallia, Natalia Shcherbik, et al.. (1998). Association of Purα with RNAs Homologous to 7 SL Determines Its Binding Ability to the Myelin Basic Protein Promoter DNA Sequence. Journal of Biological Chemistry. 273(35). 22241–22247. 39 indexed citations
20.
Muralidharan-Chari, Vandhana, et al.. (1997). Evidence for inhibition of MyEF-2 binding to MBP promoter by MEF-1/Pur α. Journal of Cellular Biochemistry. 66(4). 524–531. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amélie Robert Breakdown of academic impact, for papers by R. Stephens Breakdown of academic impact, for papers by Volker Patzel Breakdown of academic impact, for papers by Kathryn S. Campbell Breakdown of academic impact, for papers by Patrick Champion-Arnaud Breakdown of academic impact, for papers by Marc S. Krug Breakdown of academic impact, for papers by Aarthi Ashok Breakdown of academic impact, for papers by Gregory E. Tullis Breakdown of academic impact, for papers by Toru Uchiyama Breakdown of academic impact, for papers by Erika Marsilio
Rankless by CCL
2026